Canine diffuse large B-cell lymphoma downregulates the activity of CD8 + T-cells through tumor-derived extracellular vesicles

• Published in: Cancer cell international Vol. 23; no. 1; pp. 1 - 252
• Main Authors: Weng, Hsin-Pei, Ke, Chiao-Hsu, Tung, Chun-Wei, Tani, Akiyoshi, Wang, Chia-Chi, Yang, Wen-Yuan, Wang, Yu-Shan, Han, Winston, Liao, Chi-Hsun, Tomiyasu, Hirotaka, Lin, Chen-Si
• Format: Journal Article
• Language: English
• Published: London BioMed Central 26.10.2023; BMC
• Subjects: Angiogenesis; Antibodies; Antitumor agents; Apoptosis; B-cell lymphoma; CD8 antigen; CD8 + T-cell; Cell activation; Cell culture; Cell interactions; Cell-mediated immunity; Cloning; CTLA-4 blockade; CTLA-4 protein; Diffuse large B-cell lymphoma; Dogs; Extracellular vesicles; Flow cytometry; Foxp3 protein; Gene expression; Immune suppression; Invoices; Ligands; Lymphatic system; Lymphocytes B; Lymphocytes T; Lymphoma; Malignancy; Metastases; PD-1 protein; PD-L1 protein; Phenotypes; Plasma; Proteins; Tumor microenvironment; Tumors; Veterinary medicine; United Kingdom > UK; United States > US
• ISSN: 1475-2867; 1475-2867
• DOI: 10.1186/s12935-023-03104-4

Abstract Background Tumor-derived extracellular vesicles (EVs) have been proposed as the essential mediator between host immunity and cancer development. These EVs conduct cellular communication to facilitate tumor growth, enable invasion and metastasis, and shape the favorable tumor microenvironment. Lymphoma is one of the most common hematological malignancies in humans and dogs. Effective T-cell responses are required for the control of these malignancies. However, the immune crosstalk between CD8 + T-cells, which dominates anti-tumor responses, and canine lymphoma has rarely been described. Methods This study investigates the immune manipulating effects of EVs, produced from the clinical cases and cell line of canine B cell lymphoma, on CD8 + T-cells isolated from canine donors. Results Lymphoma-derived EVs lead to the apoptosis of CD8 + T-cells. Furthermore, EVs trigger the overexpression of CTLA-4 on CD8 + T-cells, which indicates that EV blockade could serve as a potential therapeutic strategy for lymphoma patients. Notably, EVs transform the CD8 + T-cells into regulatory phenotypes by upregulating their PD-1, PD-L1, and FoxP3 mRNA expression. The regulatory CD8 + T-cells secret the panel of inhibitory cytokines and angiogenic factors and thus create a pro-tumorigenic microenvironment. Conclusion In summary, the current study demonstrated that the EVs derived from canine B cell lymphoma impaired the anti-tumor activity of CD8 + T-cells and manipulated the possible induction of regulatory CD8 + T-cells to fail the activation of host cellular immunity.